Market Overview

Lazard Capital Markets Initiated Coverage on Nektar Therapeutics at Buy, Announced $15.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for NKTR

DateFirmActionFromTo
Sep 2017MizuhoInitiates Coverage OnBuy
Aug 2017H.C. WainwrightInitiates Coverage OnBuy
Nov 2016Aegis CapitalInitiates Coverage OnBuy

View More Analyst Ratings for NKTR
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (NKTR)

Partner Center

Loading...